Hyperscale Data's subsidiary, askROI, an AI technology company with a platform featuring over 240 productivity tools and generative AI, aims to become a separate publicly traded company by mid to late 2027 through an IPO, RTO, or SPAC. This move is intended to unlock shareholder value by allowing askROI to establish its own market valuation and accelerate growth independently. Leadership changes are planned to support this transition, with Joseph Spaziano and Ryan Doucette expected to lead askROI post-transaction. The listing aligns with Hyperscale Data's strategy to create transparency and growth opportunities for its subsidiaries.
Hyperscale Data's plan for its askROI subsidiary to go public in 2027 is provided here with Technology-sector market data from Pluang. As of Oct 17, 2026 03:31 WIB, 27 out of 150 priced Technology-sector US stocks rose while 122 fell. Notable movers include Applied Digital Corporation (APLD) at USD 18.20 with a 1-day change of -10.74%, AXT Inc (AXTI) at USD 51.89 down 10.40%, and Cipher Mining Inc (CIFR) at USD 9.00 down 10.36%.
Changan Automobile announced new partnerships covering seven European markets and launched its "with U" service program at Mondial de l’Auto 2026. This marks a shift from market entry to building a local ecosystem including manufacturing, sales, serv...
At the 2026 Mondial de l’Auto, Changan Automobile signed letters of intent with eight companies across seven European markets and launched its "with U" service program. This marks a strategic move to build a strong local ecosystem combining manufactu...
Northland Power Inc. announced it will release its third quarter 2026 financial results after market close on November 12, 2026. The company will host an earnings call and webcast on November 13 at 9:00 a.m. ET, providing investors an opportunity to ...
Several daily leveraged ETFs tied to tech and crypto-related stocks dropped sharply, with declines over 20%. Notable falls include GraniteShares 2x Long NBIS Daily ETF down 24.5% and Leverage Shares 2x Long CRWV Daily ETF down 23.9%. These ETFs aim t...
Recent biotech IPOs Iambic Therapeutics and City Therapeutics saw significant price jumps, rising 25.9% and 22.2% respectively after their market debuts, raising substantial capital. Inverse leveraged ETFs SMCZ and SMST also gained sharply as their u...
